Cargando…
Antibiotic prophylaxis in acute childhood leukemia: What is known so far?
INTRODUCTION: The treatment of acute lymphoblastic leukemia (ALL) has evolved in recent decades, reaching an overall survival rate close to 90%. Currently, approximately 4% of patients with ALL die from secondary complications of chemotherapy. Among these complications, the most frequent is febrile...
Autores principales: | Dufrayer, Mauro Cesar, Monteiro, Yasmine Massaro Carneiro, Carlesse, Fabianne Altruda de Moraes Costa, Motta, Fabrizio, Daudt, Liane Esteves, Michalowski, Mariana Bohns |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627853/ https://www.ncbi.nlm.nih.gov/pubmed/36522273 http://dx.doi.org/10.1016/j.htct.2022.09.1279 |
Ejemplares similares
-
Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil
por: Dufrayer, Mauro Cesar, et al.
Publicado: (2023) -
From H1N1 to COVID-19: What we have seen in children with hemoglobinopathies
por: Oliveira, Claudia de Melo, et al.
Publicado: (2022) -
Allergic reactions to asparaginase: retrospective cohort study in pediatric patients with acute lymphoid leukemia
por: Battistel, Ana Paula, et al.
Publicado: (2021) -
Influence of minimal residual disease by multiparametric flow cytometry at day 15 of induction in risk stratification of children with B-cell acute lymphoblastic leukemia treated at a referral hospital in southern Brazil
por: Silva, Klerize Anecely de Souza, et al.
Publicado: (2020) -
TRPA1 Role in Inflammatory Disorders: What Is Known So Far?
por: Landini, Lorenzo, et al.
Publicado: (2022)